3-46989114-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015175.3(NBEAL2):c.299G>A(p.Gly100Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,613,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015175.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NBEAL2 | NM_015175.3 | c.299G>A | p.Gly100Asp | missense_variant | 4/54 | ENST00000450053.8 | NP_055990.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NBEAL2 | ENST00000450053.8 | c.299G>A | p.Gly100Asp | missense_variant | 4/54 | 2 | NM_015175.3 | ENSP00000415034 | P2 | |
NBEAL2 | ENST00000651747.1 | c.278G>A | p.Gly93Asp | missense_variant | 4/53 | ENSP00000499216 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000485 AC: 12AN: 247644Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134750
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461480Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727012
GnomAD4 genome AF: 0.000151 AC: 23AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74364
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.299G>A (p.G100D) alteration is located in exon 4 (coding exon 4) of the NBEAL2 gene. This alteration results from a G to A substitution at nucleotide position 299, causing the glycine (G) at amino acid position 100 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at